Version 2.78

Term Description

This term is for the evaluation of microsatellite instability and mutation within all coding regions and exon/intron boundaries of 39 genes for bladder and prostate cancer.
Source: Regenstrief LOINC

Fully-Specified Name

Component
Bladder & Prostate cancer multigene analysis
Property
Find
Time
Pt
System
Tiss
Scale
Doc
Method
Molgen

Additional Names

Short Name
Bladder & Prostate CA mltgn anlyss Tiss
Display Name
Bladder and Prostate cancer multigene analysis Molgen Doc (Tiss)
Consumer Name Alpha Get Info
Bladder and Prostate cancer multigene analysis, Tissue

Associated Observations

82939-0 Genetic variant details in Blood or Tissue by Molecular genetics method Narrative

Narrative information (unstructured) about a genetic variant. The results may state that a mutation was not identified or include the variant(s) found. The location of the variant may be described at various levels, such as genomic (g.), coding (c.), and protein (p.) levels. Details may also include alternate identifiers for the variant (e.g dbSNP ID, Transcript reference sequence ID), the clinical significance (e.g. pathogenic, variant of unknown significance) and the change type (e.g. homozygous, heterozygous, wild type).

69047-9 Geneticist review of results

48767-8 Annotation comment [Interpretation] Narrative

This is an observation code indicating that a particular observation represents a free text annotation comment that can be appended to some other observation such as a lab result.

31208-2 Specimen source identified

80398-1 Unique identifier for Current sample

85069-3 Lab test method [Type]

The lab test method code is used to report the specific test method used in the laboratory.

18771-6 Provider signing name

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.78
Last Updated
Version 2.78
Order vs. Observation
Order

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=105589-6